Seeing Through the Haze: The Radiologist’s Challenge in Diffuse Liver Disease

Abstract

Get full access to this article

View all access options for this article.

References

Mahmoud

Abdelmalek

MF.

The liver in diabetes and metabolic syndrome. Clin Liver Dis. 2025;29:407-429.

Shyamanur

Khalili

Elbanna

KY.

The impact of diffuse liver disease on liver lesion detection and characterization. Can Assoc Radiol J. Published online November 5, 2025. doi:10.1177/08465371251383887

Bizeul

Ronot

Roux

, et al. Evaluation of washout using subtraction MRI for the diagnosis of hepatocellular carcinoma in cirrhotic patients with spontaneously T1-hyperintense nodules. Diagn Interv Imaging. 2023;104(9):427-434.

Soyer

Sirol

Fargeaudou

, et al. Differentiation between true focal liver lesions and pseudolesions in patients with fatty liver: evaluation of helical CT criteria. Eur Radiol. 2010;20:1726-1737.

Fortier

Mohamed

McNabb

, et al. R₂* impact on hepatic fat quantification with a commercial single voxel technique at 1.5 and 3.0 T. Can Assoc Radiol J. 2024;75(4):838-846.

Park

Son

Choi

SH.

Imaging features of hepatocellular carcinoma in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: a systematic review and meta-analysis. Abdom Radiol. 2022;47(6):2089-2098.

Barat

Nguyen

TTL

Hollande

, et al. LI-RADS v2018 major criteria: do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI? Eur J Radiol. 2021;138:109651.